4//SEC Filing
Yuan Qing Sarah 4
Accession 0001415889-23-011523
CIK 0001821323other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:21 PM ET
Size
7.4 KB
Accession
0001415889-23-011523
Insider Transaction Report
Form 4
Yuan Qing Sarah
CTOO
Transactions
- Exercise/Conversion
Common Stock
2023-07-27$19.24/sh+2,884$55,488→ 2,884 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-07-27−2,884→ 6,346 totalExercise: $19.24Exp: 2032-03-06→ Common Stock (2,884 underlying)
Footnotes (2)
- [F1]The option vested as to 25% of the underlying shares of common stock on March 7, 2023, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.
- [F2]Effective May 22, 2023, the Issuer effected a 1-for-13 reverse stock split (the "Reverse Split") of its issued and outstanding shares of Common Stock. Cash was paid in lieu of any fractional shares resulting from the Reverse Split. The Reporting Person's beneficial ownership in this Form 4 has been adjusted for the Reverse Split.
Documents
Issuer
Sigilon Therapeutics, Inc.
CIK 0001821323
Entity typeother
Related Parties
1- filerCIK 0001907487
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 4:21 PM ET
- Size
- 7.4 KB